Pyros Pharmaceuticals is dedicated to developing enhanced specialty pharmaceuticals for rare diseases. Pyros's mission is to elevate the standard of care for infantile spasms, providing treatment options that significantly improve the lives of affected children. Through innovative therapies and comprehensive support, Pyros helps providers and caregivers navigate the complex patient journey. 

Pyros Pharmaceuticals, Inc. announced it raised $450,000 in an initial filing from an offering of $5 Million

Company Information

Funding Insights

Pyros Pharmaceuticals, Inc. announced it raised $450,000 in an initial filing from an offering of $5 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information